openPR Logo
Press release

RNAi Technologies Market Analysis Focusing on Top Key Players – Alnylam Pharmaceuticals, Benitec Biopharma Ltd, Filmtec Corporation, Ionis Pharmaceuticals, Quark Pharmaceuticals Inc, RXI Pharmaceuticals, Qiagen & More

11-06-2018 10:56 AM CET | Health & Medicine

Press release from: marketstudyreport.com

RNAi Technologies

RNAi Technologies

MarketStudyReport.com present the report on Global RNAi Technologies Market by Manufacturers, Regions, Type and Application, forecast to 2023 evaluates the growth trends of the industry through historical study and estimates future prospects based on comprehensive research. The report extensively provides the market share, growth, trends and forecasts for the period 2018-2023.

RNAi (Ribonucleic Acid Interference) a system in live cells to keep a check on the active genes is the next promising technology in the field of biotechnology. The major classes of RNAi are micro RNA and small interfering RNA. RNAi is said to be the replacement technology for the existing recombinant technology in the field of drug discovery and therapeutics.

Request Sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/1302190/

This report studies the RNAi Technologies Market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the RNAi Technologies market by product type and applications/end industries.

The worldwide market for RNAi Technologies is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new Research study.

Market Segment by Manufacturers, this report covers:
Alnylam Pharmaceuticals, Benitec Biopharma Ltd, Filmtec Corporation, Ionis Pharmaceuticals, Quark Pharmaceuticals Inc, RXI Pharmaceuticals, Qiagen, Invitrogen, Ambion.

Market Segment by Type, covers:

Oncology

Ocular disorders

Respiratory disorders

Liver diseases

Other

Market Segment by Applications, can be divided into:
Research
Therapeutics

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/1302190/

Market Segment by Regions, regional analysis covers:
North America (USA, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Columbia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa).

There are 15 Chapters to deeply display the global RNAi Technologies market.

Chapter 1, to describe RNAi Technologies Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of RNAi Technologies, with sales, revenue, and price of RNAi Technologies, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of RNAi Technologies, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, RNAi Technologies market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe RNAi Technologies sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

More Details on this Report At: https://www.marketstudyreport.com/reports/global-rnai-technologies-market-2018-by-manufacturers-regions-type-and-application-forecast-to-2023

Related Report:

Global RNAi Technologies Market Growth 2018-2023

This report presents a comprehensive overview, market shares, and growth opportunities of RNAi Technologies market by product type, application, key manufacturers and key regions.

https://www.marketstudyreport.com/reports/global-rnai-technologies-market-growth-2018-2023/?utm_source=RR-PSR

About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:
Market Study Report
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release RNAi Technologies Market Analysis Focusing on Top Key Players – Alnylam Pharmaceuticals, Benitec Biopharma Ltd, Filmtec Corporation, Ionis Pharmaceuticals, Quark Pharmaceuticals Inc, RXI Pharmaceuticals, Qiagen & More here

News-ID: 1354793 • Views:

More Releases from marketstudyreport.com

Load Bank Market Growth Prospectus by 2028 - Business Opportunities by ASCO Power Technologies (Schneider Electric), Simplex, Shenzhen Sikes, Pite Tech
Load Bank Market Growth Prospectus by 2028 - Business Opportunities by ASCO Powe …
A concise assortment of data on the 'Load Bank Market' offers an exhaustive study targeting current market trends influencing the business across assorted regions. Significant details related to market size, market share, applications, and statistics are put together to convey an ensemble prediction of the industry. The research further focuses on comprehensive competitor analysis in addition to highlighting growth strategies embraced by market leaders. Load Bank Market Size was estimated
Agriculture Equipment Market is Expected to Reach USD 161640 Million by 2028 - John Deere, CNH Industrial, Kubota, AGCO, Claas, Yanmar, Mahindra, LOVOL
Agriculture Equipment Market is Expected to Reach USD 161640 Million by 2028 - J …
Global Agriculture Equipment Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of the market with the geographical landscape, demand, remuneration scale, and growth of this vertical have also been included in this report. Global Agriculture Equipment Market Size was estimated at USD 114110 million in 2021 and is projected to reach USD 161640 million by 2028, exhibiting a CAGR of
Electric Vehicle Market Size to grow at a CAGR of 23.5% through 2028| Tesla Inc., Volkswagen AG, SAIC Motors, BYD Auto Co. Ltd., BMW Group, Nissan Motor Co. Ltd., Hyundai Group
Electric Vehicle Market Size to grow at a CAGR of 23.5% through 2028| Tesla Inc. …
Global Electric Vehicle Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of market with the geographical landscape, demand, remuneration scale, and growth of this vertical have also been included in this report. The electric vehicles (EVs) market is estimated to witness a robust growth rate of 23.5% during the period 2019-2028. The operation is done to stop ligament tears and
Fuel Cell Air Compressor Market is Expected to Reach USD 512.3 Million by 2028 - Garrett Motion, Hanon Systems, UQM Technologies, FISCHER Fuel Cell Compressor
Fuel Cell Air Compressor Market is Expected to Reach USD 512.3 Million by 2028 - …
Global Fuel Cell Air Compressor Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of market with the geographical landscape, demand, remuneration scale, and growth of this vertical have also been included in this report. Global Fuel Cell Air Compressor Market Size was estimated at USD 215.1 million in 2021 and is projected to reach USD 512.3 million by 2028, exhibiting

All 5 Releases


More Releases for RNA

Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand. Browse 156 Market Data Tables and 112 Figures spread through 175
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The …
With less than 4 weeks until SMi’s 10th annual RNA Therapeutics event (http://www.therapeutics-rna.com/openpr) opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited. Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploring
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year. Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018! Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion. One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and